Regarding renal impairment, the use of valsartan 80 mg as the starting dose, with no dosage adjustment, in patients with reduced renal function (creatinine clearance rate > 10 ml/ min) is supported by both efficacy and safety data from Study 27 and by pharmacokinetic data from Study 12.